The overall goal of this program is to determine the basic mechanisms underlying the regulation of the physiology and pharmacology of basal ganglia amino acid and peptidergic pathways. Within this context, our interests proceed from the behavioral level to the synaptic and molecular level. We are interested in understanding the regulation of the physiological properties of the basal ganglia after selective lesions in relation to motor behavior, the neurotransmitters used in accomplishing this behavior, and the fundamental characteristics of the neurotransmitter receptors that are involved. Our specific goals are as follows: 1. Study the effects of excitotoxic lesions of GABAergic and glutamatergic connections of the basal ganglia on unit activity and motor performance in animals trained to carry out a motor task. 2. Test the hypothesis that the subthalamic nucleus is glutamatergic and is a convergence point for the regulation of striatal and pallidal output and determine whether cortical and thalamic striatal afferents differentially affect striatal neuron subpopulations. 3. Determine the kinetic properties of the GABAA, NMDA and quisqualate receptor channels and the mechanisms by which drugs and ions regulate these properties. 4. Investigate the mechanisms by which neuropeptide Y and somatostatin receptors are coupled to voltage dependent calcium channels.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (SRC (05))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Deng, Y P; Albin, R L; Penney, J B et al. (2004) Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat 27:143-64
Greenfield Jr, L John; Zaman, Shahid H; Sutherland, Margaret L et al. (2002) Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement. Neuropharmacology 42:502-21
Greene, J G; Sheu, S S; Gross, R A et al. (1998) 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84:503-10
Wullner, U; Standaert, D G; Testa, C M et al. (1997) Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain. Brain Res 768:215-23
Aldridge, J W; Thompson, J F; Gilman, S (1997) Unilateral striatal lesions in the cat disrupt well-learned motor plans in a GO/NO-GO reaching task. Exp Brain Res 113:379-93
Gross, R A; Covey, D F; Ferrendelli, J A (1997) Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones. J Pharmacol Exp Ther 280:686-94
Kume, A; Greenfield Jr, L J; Macdonald, R L et al. (1996) Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor. J Pharmacol Exp Ther 277:1784-92
Kaatz, K W; Albin, R L (1996) Intraseptal administration of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid induces immediate early gene expression in lateral septal neurons. Brain Res 709:205-14
Milbrandt, J C; Albin, R L; Turgeon, S M et al. (1996) GABAA receptor binding in the aging rat inferior colliculus. Neuroscience 73:449-58
Penney, J B; Standaert, D G; Testa, C M et al. (1996) Glutamate receptor genes in Parkinson's disease. Adv Neurol 69:79-86

Showing the most recent 10 out of 151 publications